Showing results (181-190 of 956) with videos related to
Sort By:
Pageof 96
Journal of Psychiatric Research|February 21, 2012
T-817MA, a novel neurotrophic agent, ameliorates loss of GABAergic parvalbumin-positive neurons and sensorimotor gating deficits in rats transiently exposed to MK-801 in the neonatal periodTakashi Uehara, Tomiki Sumiyoshi, Hiroshi Hattori, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 23, 2005
Perospirone in the treatment of schizophrenia: effect on verbal memory organizationTsuyoshi Araki, Hidenori Yamasue, Tomiki Sumiyoshi, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 18, 2008
Calcineurin A gamma and B gene expressions in the whole blood in Japanese patients with schizophreniaMasahiko Murata, Masahiko Tsunoda, Tomiki Sumiyoshi, et al.Psychiatry and Clinical Neurosciences|May 20, 2014
Long-term efficacy and safety of blonanserin in patients with first-episode schizophrenia: a 1-year open-label trialYuriko Ninomiya, Seiya Miyamoto, Tomomi Tenjin, et al.Neuropsychiatric Disease and Treatment|November 10, 2022
Validation and Functional Relevance of the Short Form of the Perceived Deficits Questionnaire for Depression for Japanese Patients with Major Depressive DisorderTomiki Sumiyoshi, Hiroyuki Uchida, Koichiro Watanabe, et al.Frontiers in Psychiatry|August 11, 2023
Analysis of polyunsaturated fatty acids in antipsychotic-free individuals with at-risk mental state and patients with first-episode schizophreniaAnh Thi Phuong Le, Yuko Higuchi, Tomiki Sumiyoshi, et al.Neuropsychiatric Disease and Treatment|January 19, 2024
Goal Attainment Scaling for Depression: Validation of the Japanese GAS-D Tool in Patients with Major Depressive DisorderMasaki Kato, Toshiaki Kikuchi, Koichiro Watanabe, et al.Antioxidants & Redox Signaling|August 18, 2010
Magnetic resonance spectroscopy study of the antioxidant defense system in schizophreniaDaisuke Matsuzawa, Kenji HashimotoGan to Kagaku Ryoho. Cancer & Chemotherapy|July 22, 2010
[Breakthrough breast cancer treatment--PARP inhibitor, BRCA, and triple negative breast cancer]Kenji Hashimoto, Kenji TamuraAnnals of General Psychiatry|April 27, 2010
Fluvoxamine for blonanserin-associated akathisia in patients with schizophrenia: report of five casesTsutomu Furuse, Kenji HashimotoPageof 96